Related Articles| Protox Announces Positive 12 Month Data from BPH Study Vancouver, BC, October 8, 2008--(T-Net)--Protox Therapeutics (TSX: PRX), a leader in the development of receptor targeted fusion proteins, today announced positive 12 month data from its Phase 1 study of PRX302 in patients with benign prostatic hyperplasi |
| Review The Thyroid Diet by Mary Shomon If you're a thyroid patient who experiences problems with weight gain and difficulty losing weight, this review of Mary Shomon's book is a must read! The book also helps thyroid patients benefit more from their treatments and live healthier lives! |
|